DarioHealth Corp. (DRIO) P/E Ratio History
Historical price-to-earnings valuation from 2025 to 2025
Loading P/E history...
DRIO Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, DarioHealth Corp. (DRIO) trades at a price-to-earnings ratio of 6.6x, with a stock price of $8.13 and trailing twelve-month earnings per share of $1.24.
The current P/E is 96% below its 5-year average of 177.0x. Over the past five years, DRIO's P/E has ranged from a low of 5.1x to a high of 335.0x, placing the current valuation at the 25th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, DRIO trades at a 71% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, DRIO trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DRIO DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DRIO P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $2B | 978.1 | - | -84% | |
| $7B | 50.3 | - | -4% | |
| $24B | 29.1 | 2.78 | +47% | |
| $151B | 11.4Lowest | 0.38Best | +134%Best | |
| $11B | 46.1 | 0.45 | -40% | |
| $973M | 33.3 | - | +104% | |
| $111B | 62.8 | - | -62% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
DRIO Historical P/E Data (2025–2025)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2025 Q4 | Wed Dec 31 2025 00:00:00 GM | $11.38 | $2.22 | 5.1x | -97% |
| FY2025 Q3 | $17.35 | $0.06 | 289.2x | +63% | |
| FY2025 Q2 | Mon Jun 30 2025 00:00:00 GM | $13.40 | $0.04 | 335.0x | +89% |
| FY2025 Q1 | Mon Mar 31 2025 00:00:00 GM | $12.24 | $0.16 | 78.8x | -56% |
Average P/E for displayed period: 177.0x
See DRIO's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DRIO Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DRIO vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDRIO — Frequently Asked Questions
Quick answers to the most common questions about buying DRIO stock.
Is DRIO stock overvalued or undervalued?
DRIO trades at 6.6x P/E, below its 5-year average of 177.0x. At the 25th percentile of historical range, the stock is priced at a discount to its own history.
How does DRIO's valuation compare to peers?
DarioHealth Corp. P/E of 6.6x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is DRIO's PEG ratio?
DRIO PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2025-2025.